Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: sloan who wrote (9011)	6/3/1998 12:50:00 PM
From: Tim Gardner	Read Replies (3) \| Respond to of 23519

Sloan, get a clue. Don't try to manipulate the members of this thread with excerpts from a trash study that tested only 100 men whose average age was 65. If you think that study shows the consensus opinion about Muse, then by all means short the stock at these levels and ride it to 0. If in fact Muse only worked 27% of the time, then it is amazing that it was the number one sought treatment before Viagra came out. The poor journalistic trash that has been coming out about Vivus in the past two days will by know means scare the longs that have been following this company for some time and actually know what this company's true value is. We know that Muse works and we know we are being manipulated right now. But we also know that the facts will speak for themselves in a month and no amount of negative crap is going to stop the truth from coming out. I can wait another month, the question is -- Can the shorts?